MHIP vs. IBRN

Last updated Jul 8, 2026

MHIP (Milliman Healthcare Inflation Plus ETF) and IBRN (iShares Neuroscience and Healthcare ETF) are both Health & Biotech Equities funds. MHIP is actively managed, while IBRN is passively managed. A 0.54 correlation means they provide meaningful diversification when combined. MHIP charges 0.55%/yr vs 0.47%/yr for IBRN.

Performance

MHIP vs. IBRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Milliman Healthcare Inflation Plus ETF (MHIP) and iShares Neuroscience and Healthcare ETF (IBRN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MHIP

• 1D: 0.26%
• 1M: 2.51%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IBRN

• 1D: 1.52%
• 1M: 15.98%
• 6M: 25.66%
• YTD: 22.56%
• 1Y: 82.20%
• 3Y*: 19.47%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

MHIP vs. IBRN - Yearly Performance Comparison

	2026 (YTD)
MHIP Milliman Healthcare Inflation Plus ETF	1.64%
IBRN iShares Neuroscience and Healthcare ETF	11.99%

Correlation

The correlation between MHIP and IBRN is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026	0.54

Return for Risk

MHIP vs. IBRN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MHIP

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

IBRN

IBRN Risk / Return Rank: 95
IBRN Sharpe Ratio Rank: 96
IBRN Sortino Ratio Rank: 94
IBRN Omega Ratio Rank: 91
IBRN Calmar Ratio Rank: 97
IBRN Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MHIP vs. IBRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Milliman Healthcare Inflation Plus ETF (MHIP) and iShares Neuroscience and Healthcare ETF (IBRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MHIP	IBRN	Difference
Sharpe ratio: Return per unit of total volatility	—	3.25	—
Sortino ratio: Return per unit of downside risk	—	4.14	—
Omega ratio: Gain probability vs. loss probability	—	1.49	—
Calmar ratio: Return relative to maximum drawdown	—	9.39	—
Martin ratio: Return relative to average drawdown	—	26.57	—

Drawdowns

MHIP vs. IBRN - Drawdown Comparison

The maximum MHIP drawdown since its inception was -3.09%, smaller than the maximum IBRN drawdown of -35.38%. Use the drawdown chart below to compare losses from any high point for MHIP and IBRN.

Drawdown Indicators

	MHIP	IBRN	Difference
Max Drawdown Largest peak-to-trough decline	-3.09%	-35.38%	+32.29%
Max Drawdown (1Y) Largest decline over 1 year	—	-8.80%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-35.38%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-1.28%	-9.66%	+8.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.10%	—

Volatility

Volatility by Period

	MHIP	IBRN	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.51%	—
Volatility (6M) Calculated over the trailing 6-month period	—	19.12%	—
Volatility (1Y) Calculated over the trailing 1-year period	11.86%	25.50%	-13.64%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	11.86%	25.31%	-13.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	11.86%	25.31%	-13.45%

MHIP vs. IBRN - Expense Ratio Comparison

MHIP has a 0.55% expense ratio, which is higher than IBRN's 0.47% expense ratio.

Dividends

MHIP vs. IBRN - Dividend Comparison

MHIP has not paid dividends to shareholders, while IBRN's dividend yield for the trailing twelve months is around 0.81%.

Position	TTM	2025	2024	2023
IBRN iShares Neuroscience and Healthcare ETF	0.81%	0.99%	0.40%	0.06%
MHIP Milliman Healthcare Inflation Plus ETF	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both MHIP and IBRN in my portfolio?

MHIP and IBRN have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, MHIP or IBRN?

On fees, IBRN is cheaper at 0.47% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, MHIP or IBRN?

IBRN is cheaper with a 0.47% expense ratio, compared with 0.55% for MHIP.

Which ETF pays a higher dividend yield, MHIP or IBRN?

IBRN has the higher dividend yield at 0.81%, compared with 0.00% for MHIP.

What is the main difference between MHIP and IBRN?

They also come from different issuers: Milliman and iShares. Their fees differ too: 0.55% for MHIP and 0.47% for IBRN.